Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder

Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis

(2021) Olwen C. Murphy et al.   Frontiers in Neurology

Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD

(2021) Dean M. Wingerchuk et al.   ANNALS OF NEUROLOGY

Foveal changes in AQP4‐Ab seropositive NMOSD are independent of optic neuritis and not overtly progressive

(2021) Adriana Roca‐Fernández et al.   EUROPEAN JOURNAL OF NEUROLOGY

Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis

(2021) Jeffrey Lambe et al.   NEUROLOGY

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: a longitudinal study

(2021) Athina Papadopoulou et al.   NeuroImage-Clinical

Optical Coherence Tomography Angiography of Peripapillary Vessel Density in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Comparative Study

(2021) Małgorzata Rogaczewska et al.   Journal of Clinical Medicine

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

(2021) Orhan Aktas et al.   ANNALS OF NEUROLOGY

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

(2021) Patrick Schindler et al.   Journal of Neuroinflammation

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

(2021) Elia Sechi et al.   JAMA Neurology

Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies

(2021) Xuechun Chang et al.   Frontiers in Immunology

Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder

(2021) Jae-Won Hyun et al.   Neurology-Neuroimmunology & Neuroinflammation

Optic Neuritis–Independent Retinal Atrophy in Neuromyelitis Optica Spectrum Disorder

(2021) Angeliki G. Filippatou et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?

(2021) Samuel B. Marcucci et al.   Multiple Sclerosis and Related Disorders

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

(2020) Romana Höftberger et al.   ACTA NEUROPATHOLOGICA

Anti-myelin oligodendrocyte glycoprotein antibody associated disease spectrum – A north Indian tertiary care centre experience and review of literature

(2020) Radhakrishna Pedapati et al.   JOURNAL OF NEUROIMMUNOLOGY

Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population

(2020) Weihe Zhang et al.   JOURNAL OF NEUROLOGY

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

(2020) Thaís Armangue et al.   LANCET NEUROLOGY

MRI differences between MOG antibody disease and AQP4 NMOSD

(2020) Sara Salama et al.   Multiple Sclerosis Journal

The Detection of Retina Microvascular Density in Subclinical Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders

(2020) Yihong Chen et al.   Frontiers in Neurology

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

(2020) Elias S. Sotirchos et al.   ANNALS OF NEUROLOGY

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study

(2020) Yoshiki Takai et al.   BRAIN

Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study

(2020) Xiayin Zhang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease

(2020) Hyunjin Kim et al.   Neurology-Neuroimmunology & Neuroinflammation

MOG Antibody Associated Disease: How it Differs From and Resembles Other Neuroinflammatory Disorders

(2020) Mona Shahriari et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Progressive brain atrophy and white matter changes in MOG encephalomyelitis

(2020) Young Nam Kwon et al.   NEUROLOGY

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

(2020) Ludwig Kappos et al.   JAMA Neurology

MOG-antibody-associated hypertrophic pachymeningitis

(2020) Athanasios Papathanasiou et al.   Multiple Sclerosis and Related Disorders

Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials

(2020) Tao Xue et al.   Multiple Sclerosis and Related Disorders

Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders

(2020) Seyedamirhosein Motamedi et al.   Neurology-Neuroimmunology & Neuroinflammation

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

(2020) Sven Jarius et al.   Journal of Neuroinflammation

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

(2020) Sven Jarius et al.   Journal of Neuroinflammation

Incidence of inter-attack asymptomatic brain lesions in NMO spectrum disorder

(2020) Min Young Lee et al.   NEUROLOGY

Atypical MOG antibody disease presenting with typical multiple sclerosis lesions

(2020) Katelyn Dolbec et al.   Multiple Sclerosis and Related Disorders

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis

(2020) Angeliki G. Filippatou et al.   Frontiers in Neurology

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders

(2020) Simon Rinaldi et al.   Neurology-Neuroimmunology & Neuroinflammation

Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders

(2020) Tetsuya Akaishi et al.   JOURNAL OF NEUROIMMUNOLOGY

Primary progression in NMOSD. Does it really exist?

(2020) Dimitrios Parissis et al.   Multiple Sclerosis and Related Disorders

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

(2019) J. William L. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Retinal measurements predict 10-year disability in multiple sclerosis

(2019) Alissa Rothman et al.   Annals of Clinical and Translational Neurology

Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G–Positive Neuromyelitis Optica Spectrum Disorder

(2019) Yuyi You et al.   OPHTHALMOLOGY

MOG antibody–associated encephalomyelitis/encephalitis

(2019) Sara Salama et al.   Multiple Sclerosis Journal

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders

(2019) Athina Papadopoulou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures

(2019) Olwen C Murphy et al.   Multiple Sclerosis Journal

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults

(2019) CL de Mol et al.   Multiple Sclerosis Journal

MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis

(2019) Toshikazu Baba et al.   Multiple Sclerosis and Related Disorders

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study

(2019) Frederike C. Oertel et al.   Journal of Neuroinflammation

MRI features of demyelinating disease associated with anti-MOG antibodies in adults

(2019) Marc Denève et al.   JOURNAL OF NEURORADIOLOGY

MOG antibody seropositive aseptic meningitis: A new clinical phenotype

(2019) Divya Nagabushana et al.   JOURNAL OF NEUROIMMUNOLOGY

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

(2019) Bruce A C Cree et al.   LANCET

Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography

(2019) Marco Pisa et al.   Multiple Sclerosis Journal

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

(2019) Mitsuru Watanabe et al.   NEUROLOGY

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

(2019) Patrick Waters et al.   JAMA Neurology

CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease

(2019) Jacqueline F Rosenthal et al.   JOURNAL OF INVESTIGATIVE MEDICINE

MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity

(2019) Athanasios Papathanasiou et al.   JOURNAL OF NEUROLOGY

Atypical presentation of MOG-related disease: Slowly progressive behavioral and personality changes following a seizure

(2019) Ünsal Yılmaz et al.   Multiple Sclerosis and Related Disorders

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype

(2019) Laura Navarro Cantó et al.   Frontiers in Neurology

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

(2019) Marius Ringelstein et al.   NEUROLOGY

Peripapillary and parafoveal vascular network assessment by optical coherence tomography angiography in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders

(2018) Yongheng Huang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Disease-Modifying Treatment in Progressive Multiple Sclerosis

(2018) John Robert Ciotti et al.   Current Treatment Options in Neurology

Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome

(2018) Michael Eyre et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder

(2018) Nam-Hee Kim et al.   Journal of Clinical Neurology

The application of RNFL thickness detection in early differential diagnosis among various types of idiopathic optic neuritis

(2018) Xiang Zhang et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China

(2018) Lu Chen et al.   JOURNAL OF NEUROIMMUNOLOGY

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

(2018) S. Jarius et al.   Journal of Neuroinflammation

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

(2018) S. Jarius et al.   Journal of Neuroinflammation

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study

(2018) Frederike C Oertel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

Effective treatment of progressive MS remains elusive

(2018) Luanne M Metz et al.   LANCET

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

(2018) Alvaro Cobo-Calvo et al.   NEUROLOGY

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders

(2018) A. Sebastian López-Chiriboga et al.   JAMA Neurology

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease

(2018) Shahd H. M. Hamid et al.   JAMA Neurology

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report

(2018) Sara Gil-Perotin et al.   Frontiers in Neurology

Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome

(2018) John J. Chen et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China

(2018) L. Wang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

(2018) Ting Shen et al.   OPHTHALMOLOGY

Neurological update: MOG antibody disease

(2018) Ray Wynford-Thomas et al.   JOURNAL OF NEUROLOGY

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

(2018) Franziska Di Pauli et al.   Frontiers in Immunology

Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients

(2018) Ram N. Narayan et al.   Multiple Sclerosis and Related Disorders

Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder

(2017) I. H. Jeong et al.   EUROPEAN JOURNAL OF NEUROLOGY

Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis

(2017) S.-H. Kim et al.   EUROPEAN JOURNAL OF NEUROLOGY

Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica

(2017) Jie Sun et al.   EUROPEAN JOURNAL OF RADIOLOGY

Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS

(2017) Yaou Liu et al.   EUROPEAN RADIOLOGY

MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients

(2017) Lei Zhou et al.   JOURNAL OF NEUROIMMUNOLOGY

Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica

(2017) Tetsuya Akaishi et al.   JOURNAL OF NEUROIMMUNOLOGY

Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France

(2017) Damien Biotti et al.   JOURNAL OF NEUROLOGY

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases

(2017) Jae-Won Hyun et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

(2017) Sudarshini Ramanathan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evaluation of the retinal nerve fiber layer in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis

(2017) Anjiao Peng et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD)

(2017) De-Cai Tian et al.   Multiple Sclerosis Journal

Multimodal characterization of gray matter alterations in neuromyelitis optica

(2017) Yaou Liu et al.   Multiple Sclerosis Journal

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis

(2017) Roberta Lanzillo et al.   Multiple Sclerosis Journal

Diagnostic algorithm for relapsing acquired demyelinating syndromes in children

(2017) Yael Hacohen et al.   NEUROLOGY

Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome

(2017) Eva-Maria Hennes et al.   NEUROLOGY

MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice

(2017) Eva-Maria Hennes et al.   NEUROPEDIATRICS

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD)

(2017) De-Cai Tian et al.   Multiple Sclerosis Journal

Multimodal characterization of gray matter alterations in neuromyelitis optica

(2017) Yaou Liu et al.   Multiple Sclerosis Journal

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis

(2017) Roberta Lanzillo et al.   Multiple Sclerosis Journal

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases

(2017) Patrick Peschl et al.   Frontiers in Immunology

Clinicopathological features in anterior visual pathway in neuromyelitis optica

(2016) Mariko Hokari et al.   ANNALS OF NEUROLOGY

Long-term evolution of multiple sclerosis disability in the treatment era

(2016) et al.   ANNALS OF NEUROLOGY

Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study

(2016) F. Pache et al.   EUROPEAN RADIOLOGY

Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder

(2016) Praveena Manogaran et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G

(2016) Christian M. Felix et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

(2016) Florence Pache et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

(2016) Sven Jarius et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

(2016) Sven Jarius et al.   Journal of Neuroinflammation

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

(2016) Maria Sepúlveda et al.   JOURNAL OF NEUROLOGY

Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder

(2016) In Hye Jeong et al.   JOURNAL OF NEUROLOGY

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

(2016) Joachim Havla et al.   JOURNAL OF NEUROLOGY

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

(2016) Patrick Waters et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica

(2016) Praveena Manogaran et al.   NeuroImage-Clinical

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD

(2016) Bleranda Zeka et al.   Acta Neuropathologica Communications

Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)

(2016) Ryutaro Akiba et al.   PLoS One

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

(2015) Anne-Katrin Pröbstel et al.   Journal of Neuroinflammation

The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset

(2015) Helen Tedeholm et al.   JOURNAL OF NEUROLOGY

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease

(2015) Christian Lechner et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Progressive cerebral atrophy in neuromyelitis optica

(2015) Yoko Warabi et al.   Multiple Sclerosis Journal

A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis

(2015) Olivier Outteryck et al.   Multiple Sclerosis Journal

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

(2015) Sudarshini Ramanathan et al.   Multiple Sclerosis Journal

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography

(2015) JL Bennett et al.   Multiple Sclerosis Journal

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

(2015) H. J. Kim et al.   NEUROLOGY

Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker

(2015) Zhihui Yang et al.   TRENDS IN NEUROSCIENCES

Progressive cerebral atrophy in neuromyelitis optica

(2015) Yoko Warabi et al.   Multiple Sclerosis Journal

A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis

(2015) Olivier Outteryck et al.   Multiple Sclerosis Journal

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

(2015) Sudarshini Ramanathan et al.   Multiple Sclerosis Journal

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography

(2015) JL Bennett et al.   Multiple Sclerosis Journal

Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy

(2014) Yanqiang Wang et al.   BMC Neurology

Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis

(2014) Xiaogang Wang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders

(2014) Felipe von Glehn et al.   Multiple Sclerosis Journal

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

(2014) Ilana Katz Sand et al.   Multiple Sclerosis Journal

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

(2014) D. K. Sato et al.   NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies

(2014) Joanna Kitley et al.   JAMA Neurology

Optical coherence tomography – current and future applications

(2013) Mehreen Adhi et al.   CURRENT OPINION IN OPHTHALMOLOGY

Blood—Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability

(2013) Y Tomizawa et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Subclinical Optic Neuritis in Neuromyelitis Optica

(2013) Durdane Aksoy et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Visual evoked potentials in neuromyelitis optica and its spectrum disorders

(2013) Marius Ringelstein et al.   Multiple Sclerosis Journal

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica

(2013) E. S. Sotirchos et al.   NEUROLOGY

Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

(2013) Elisa Schneider et al.   PLoS One

Cognitive impairment and cortical degeneration in neuromyelitis optica

(2012) Etsuji Saji et al.   ANNALS OF NEUROLOGY

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

(2012) Sven Jarius et al.   Journal of Neuroinflammation

Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography

(2012) Danilo B. Fernandes et al.   OPHTHALMOLOGY

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

(2011) S. Jarius et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A Review of Cases of Neuromyelitis Optica

(2011) Roberto Bomprezzi et al.   NEUROLOGIST

The natural history of secondary progressive multiple sclerosis

(2010) M. Koch et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A case of chronic progressive myelopathy

(2010) Jun-Soon Kim et al.   Multiple Sclerosis Journal

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

(2010) Sven Jarius et al.   Nature Reviews Neurology

Absence of cortical demyelination in neuromyelitis optica

(2010) B. F. G. Popescu et al.   NEUROLOGY

Neuromyelitis optica: an overview

(2010) R. Nandhagopal et al.   POSTGRADUATE MEDICAL JOURNAL

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis

(2009) A J Green et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis

(2009) R. T. Naismith et al.   NEUROLOGY

Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

(2009) J. N. Ratchford et al.   NEUROLOGY

Natural history of secondary-progressive multiple sclerosis

(2008) Helen Tremlett et al.   Multiple Sclerosis Journal

Pathogenesis of Normal-appearing White Matter Damage in Neuromyelitis Optica: Diffusion-Tensor MR Imaging

(2007) Chunshui Yu et al.   RADIOLOGY